Inso Bio

Next generation DNA sample preparation

United States · Founded 2018 · $2.5M raised

Employees
1–10
Founded
2018
Website
inso.bio
Total Funding
$2.5M
Last Round
$2.2M Pre-SeedMar 2022
Rounds
2

About

Inso Biosciences is a Cornell University-originated biotech company developing a microfluidic DNA sample preparation platform for next-generation sequencing. The company's patented 'micropillar' technology physically captures and purifies high molecular weight DNA directly from blood or cell samples in as little as 10 minutes, eliminating the degradation caused by conventional bead- or column-based approaches. The system enables ultra-long DNA fragment sizes (50 kb to 1,000+ kb), lossless RNA and DNA multiomic extractions, and automated workflows compatible with any downstream sequencer. Inso Biosciences is backed by NY Ventures and several academic and institutional investors.

Summary

Inso Bio is a Biotech company based in United States, founded in 2018. It has raised $2.5M in total across 2 rounds, most recently a $2.2M Pre-Seed round in Mar 2022. Investors include 2048 Ventures.

Funding History

Pre-seedPre-SeedMar 2022
$2.2M

Sign up to see all 2 rounds

Grant through Pre-Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inso Bio on Indexed.vc
<a href="https://indexed.vc/companies/inso-bio"><img src="https://indexed.vc/api/badge/company/inso-bio" alt="Inso Bio on Indexed.vc" width="260" height="76" /></a>